AU1025199A - Coated medical implants, method for producing them, and use of the same for preventing restenosis - Google Patents
Coated medical implants, method for producing them, and use of the same for preventing restenosisInfo
- Publication number
- AU1025199A AU1025199A AU10251/99A AU1025199A AU1025199A AU 1025199 A AU1025199 A AU 1025199A AU 10251/99 A AU10251/99 A AU 10251/99A AU 1025199 A AU1025199 A AU 1025199A AU 1025199 A AU1025199 A AU 1025199A
- Authority
- AU
- Australia
- Prior art keywords
- producing
- same
- medical implants
- coated medical
- preventing restenosis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D175/00—Coating compositions based on polyureas or polyurethanes; Coating compositions based on derivatives of such polymers
- C09D175/04—Polyurethanes
- C09D175/08—Polyurethanes from polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/08—Materials for coatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/08—Materials for coatings
- A61L31/10—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Surgery (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Materials Engineering (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Materials For Medical Uses (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19744135A DE19744135C1 (de) | 1997-09-29 | 1997-09-29 | Beschichtete medizinische Implantate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Restenoseprophylaxe |
DE19744135 | 1997-09-29 | ||
PCT/EP1998/006019 WO1999016416A2 (fr) | 1997-09-29 | 1998-09-24 | Implants medicaux revetus, leur procede de preparation et leur utilisation pour la prevention de restenoses |
Publications (1)
Publication Number | Publication Date |
---|---|
AU1025199A true AU1025199A (en) | 1999-04-23 |
Family
ID=7844759
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU10251/99A Abandoned AU1025199A (en) | 1997-09-29 | 1998-09-24 | Coated medical implants, method for producing them, and use of the same for preventing restenosis |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1024842A2 (fr) |
JP (1) | JP2001517543A (fr) |
AU (1) | AU1025199A (fr) |
DE (1) | DE19744135C1 (fr) |
WO (1) | WO1999016416A2 (fr) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69734362T2 (de) | 1996-12-03 | 2006-07-20 | Sloan-Kettering Institute For Cancer Research | Synthese von epothilonen, zwischenprodukte dazu, analoga und verwendungen davon |
US6380394B1 (en) | 1996-12-13 | 2002-04-30 | The Scripps Research Institute | Epothilone analogs |
JP5140220B2 (ja) | 1999-05-27 | 2013-02-06 | バイオコンパテイブルズ・ユーケイ・リミテツド | 局所的な薬剤送達 |
ATE350077T1 (de) | 2000-04-11 | 2007-01-15 | Polyzenix Gmbh | Verwendung von folien aus poly-tri-fluor- ethoxypolyphosphazenen zur umhüllung von medizinischen vorrichtungen |
EP1179353A1 (fr) * | 2000-08-11 | 2002-02-13 | B. Braun Melsungen Ag | Implants antithrombotiques avec un revêtement de polyphosphazène et d'un agent actif |
DE10100961B4 (de) | 2001-01-11 | 2005-08-04 | Polyzenix Gmbh | Körperverträglicher Werkstoff und mit diesem Werkstoff beschichtetes Substrat für die Züchtung von Zellen und künstlichen aus Zellen aufgebauten oder gewachsenen organischen Implantaten |
US9080146B2 (en) | 2001-01-11 | 2015-07-14 | Celonova Biosciences, Inc. | Substrates containing polyphosphazene as matrices and substrates containing polyphosphazene with a micro-structured surface |
WO2003015719A1 (fr) | 2001-08-17 | 2003-02-27 | Polyzenix Gmbh | Dispositif a base de nitinol comportant un revetement polyphosphate |
DE10107795B4 (de) * | 2001-02-13 | 2014-05-15 | Berlex Ag | Gefäßstütze mit einem Grundkörper, Verfahren zur Herstellung der Gefäßstütze, Vorrichtung zur Beschichtung der Gefäßstütze |
DE50210591D1 (de) | 2001-02-16 | 2007-09-13 | Abbott Lab Vascular Entpr Ltd | Implantate mit fk506 zur restenosebehandlung und -prophylaxe |
EP1270026A1 (fr) * | 2001-06-22 | 2003-01-02 | Erik Andersen | Stents comprenant des analogues de vitamine D pour éviter les resténoses |
DE10142881A1 (de) * | 2001-09-03 | 2003-04-03 | Jomed Gmbh | Implantate mit Combretastatin A-4 (CA4) |
SI1483251T1 (sl) | 2002-03-12 | 2010-03-31 | Bristol Myers Squibb Co | C cian epotilonski derivati |
DE10231336A1 (de) * | 2002-07-11 | 2004-01-22 | Bayer Ag | Stents |
US7649006B2 (en) | 2002-08-23 | 2010-01-19 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto and analogues thereof |
DK1767535T3 (da) | 2002-08-23 | 2010-04-12 | Sloan Kettering Inst Cancer | Syntese af epothiloner, mellemprodukter deraf, analoge og deres anvendelse |
CN1723018A (zh) * | 2002-12-09 | 2006-01-18 | 诺瓦提斯公司 | 用于治疗支架狭窄的微管稳定剂 |
US8318235B2 (en) | 2003-01-22 | 2012-11-27 | Cordis Corporation | Method for applying drug coating to a medical device in surgeon room |
US20050038504A1 (en) * | 2003-01-22 | 2005-02-17 | Harry Halleriet | Kit for applying drug coating to a medical device in surgeon room |
US9107850B2 (en) | 2004-10-25 | 2015-08-18 | Celonova Biosciences, Inc. | Color-coded and sized loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same |
US20210299056A9 (en) | 2004-10-25 | 2021-09-30 | Varian Medical Systems, Inc. | Color-Coded Polymeric Particles of Predetermined Size for Therapeutic and/or Diagnostic Applications and Related Methods |
US9114162B2 (en) | 2004-10-25 | 2015-08-25 | Celonova Biosciences, Inc. | Loadable polymeric particles for enhanced imaging in clinical applications and methods of preparing and using the same |
US20060121511A1 (en) | 2004-11-30 | 2006-06-08 | Hyerim Lee | Biomarkers and methods for determining sensitivity to microtubule-stabilizing agents |
ES2378905T3 (es) | 2006-10-10 | 2012-04-19 | Celonova Biosciences, Inc. | Válvula cardiaca bioprotésica con polifosfaceno |
EP2065054A1 (fr) * | 2007-11-29 | 2009-06-03 | Bayer Schering Pharma Aktiengesellschaft | Combinaisons comprenant une prostaglandine et leurs utilisations |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3524451A1 (de) * | 1985-07-09 | 1987-03-12 | Behringwerke Ag | Mit ueberzuegen versehene formkoerper zur bindung von bioaffinen substanzen, verfahren zu ihrer herstellung sowie ihre verwendung |
US4758435A (en) * | 1986-08-11 | 1988-07-19 | American Cyanamid Company | Estradiol implant composition and method for preparation |
ES2054784T3 (es) * | 1987-08-08 | 1994-08-16 | Akzo Nv | Un metodo para la fabricacion de un implante. |
US4846844A (en) * | 1987-08-31 | 1989-07-11 | Eli Lilly And Company | Antimicrobial coated implants |
CH683673A5 (de) * | 1991-10-01 | 1994-04-29 | Otsuka Pharma Co Ltd | Antithromboseharz, Antithromboseröhrchen, Antithrombosefilm und Antithromboseüberzug. |
US5599352A (en) * | 1992-03-19 | 1997-02-04 | Medtronic, Inc. | Method of making a drug eluting stent |
US5342348A (en) * | 1992-12-04 | 1994-08-30 | Kaplan Aaron V | Method and device for treating and enlarging body lumens |
US5886026A (en) * | 1993-07-19 | 1999-03-23 | Angiotech Pharmaceuticals Inc. | Anti-angiogenic compositions and methods of use |
ATE502664T1 (de) * | 1993-07-19 | 2011-04-15 | Angiotech Pharm Inc | Herstellungsmethode eines stents mit anti- angiogener zusammensetzung |
DE4334272C2 (de) * | 1993-10-07 | 1996-07-18 | Stemberger Axel Dr | Beschichtung für Biomaterial und seine Verwendung |
CN1304058C (zh) * | 1996-03-12 | 2007-03-14 | Pg-Txl有限公司 | 水溶性紫杉醇产品 |
CN1219872A (zh) * | 1996-05-24 | 1999-06-16 | 血管技术药物公司 | 治疗或预防身体通道疾病的组合物和方法 |
-
1997
- 1997-09-29 DE DE19744135A patent/DE19744135C1/de not_active Expired - Lifetime
-
1998
- 1998-09-24 WO PCT/EP1998/006019 patent/WO1999016416A2/fr not_active Application Discontinuation
- 1998-09-24 AU AU10251/99A patent/AU1025199A/en not_active Abandoned
- 1998-09-24 EP EP98952617A patent/EP1024842A2/fr not_active Withdrawn
- 1998-09-24 JP JP2000513554A patent/JP2001517543A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2001517543A (ja) | 2001-10-09 |
WO1999016416A2 (fr) | 1999-04-08 |
EP1024842A2 (fr) | 2000-08-09 |
DE19744135C1 (de) | 1999-03-25 |
WO1999016416A3 (fr) | 1999-08-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU1025199A (en) | Coated medical implants, method for producing them, and use of the same for preventing restenosis | |
AU9091598A (en) | Coated ophthalmic and implantable devices and methods for producing same | |
AU7091900A (en) | Coating having biological activity and medical implant having surface carrying the same and method | |
AU3955795A (en) | Biocompatible coating, medical device using the same and methods | |
AU4094199A (en) | Radioactive intraluminal endovascular prosthesis and method for the treatment ofaneurysms | |
AU1053199A (en) | Exposure apparatus and method of manufacturing the same, and exposure method | |
AU1684595A (en) | Biocompatible implants | |
AU1273201A (en) | Biocompatible coated implant | |
AU5095196A (en) | Medical implants | |
AU1808197A (en) | Medical stents, apparatus and method for making same | |
AU2377300A (en) | Self-expanding prosthesis with biocompatible coating | |
AU694822B2 (en) | Biocompatible medical lead | |
EP0623687A3 (fr) | Implant à revêtement poreux et méthode pour le fabriquer. | |
AU7133298A (en) | Implantable medical device and method of manufacture | |
AU6423796A (en) | Bone prosthesis with protected coating for penetrating bone intergrowth | |
AU7287998A (en) | Bioabsorbable intermedullary implant systems and methods of use | |
HU9802422D0 (en) | Substituted isoquinoline-3-carboxamide derivatives, process for producing them and their medical use | |
AU6169998A (en) | Biocompatible polymers and methods for their use | |
AU2390695A (en) | Placement of endoprostheses and stents | |
AU5517399A (en) | Coated medical devices and implants | |
AU3031899A (en) | Nanoparticles, method for producing nanoparticles and use of the same | |
AU6457398A (en) | Odorizer or freshener article and method of making the same | |
AU2441100A (en) | Highly scratch-resistant multilayer coat, method for producing and use of the same | |
AU9016898A (en) | Methods and compositions for treatment of restenosis | |
HU9802132D0 (en) | Biphenyl-sulfonyl-cyanamides, process for producing them and their medical use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |